Filter News

Filter news

District 2-A2 Lions Sight Research Foundation, Baptist Health Foundation of San Antonio support low vision center upgrade

January 10, 2013

Thanks to two generous gifts, patients who live with limited eyesight are receiving greater services in the expanded Lions Low Vision Rehabilitation Center at The University of Texas Health Science Center at San Antonio.

San Antonio physician inventor Dr. Julio Palmaz named as fellow by National Academy of Inventors

January 8, 2013

Julio C. Palmaz, M.D., of The University of Texas Health Science Center at San Antonio was named a charter fellow by the National Academy of Inventors for his invention of the Palmaz Stent, a wire-mesh tube inserted into clogged arteries.

Study of roundworms yields potential clues in human aging

January 8, 2013

“You can learn a lot from studying a worm,” said Shane Rea, Ph.D., of the Barshop Institute for Longevity and Aging Studies, part of The University of Texas Health Science Center at San Antonio.

Study identifies promising new hepatitis C treatment

January 4, 2013

A study published this week in the New England Journal of Medicine offers hope of an effective treatment for hepatitis C with fewer ill effects than interferon therapy, which has long been the standard of care.

Brake on nerve cell activity after seizures discovered

December 19, 2012

Gene expression initiates protective electrical response

Holiday safety interviews available now

December 11, 2012

ER physicians can discuss variety of health-related topics

For Latinas, patient navigation can speed breast cancer diagnosis

December 11, 2012

Results of UT Health Science Center study published in the journal Cancer

CPRIT funds study of drug resistance in glioblastomas

December 7, 2012

Studies of how to overcome drug resistance in deadly central nervous system tumors called glioblastomas will propel forward thanks to $755,718 from the Cancer Prevention & Research Institute of Texas.

UT Health Science Center San Antonio spin-out company Rapamycin Holdings licenses drug’s intellectual property

December 7, 2012

The ability of rapamycin-related drugs to potentially slow the aging process — suggested in animal experiments at The University of Texas Health Science Center San Antonio — has led to establishment of a new San Antonio biotech company, Rapamycin Holdings Inc., which is licensing exclusive rights to intellectual property central to several aspects of the rapamycin-related drugs.

Study: Newer technology improves detection of stillbirth cause

December 6, 2012

A tool called microarray testing can help doctors to more often pinpoint the potential genetic reason for a stillbirth, so that more couples can learn what happened to their babies, a study of 500 stillbirths in San Antonio and four other cities showed.

Showing page: 369